Department of Obstetrics and Gynaecology, Women's and Newborn, Monash Health, Monash Newborn, Monash Children's Hospital, the Departments of Paediatrics and Obstetrics and Gynaecology, Monash University, and Safer Care Victoria, Melbourne, Australia.
Corresponding author: Daniel L. Rolnik, MD, PhD, Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia; email: [email protected].
Financial Disclosure Kirsten R. Palmer reports that money was paid to her institution from GlaxoSmithKline, the Cerebral Palsy Alliance, and the National Health & Medical Research Council. Ben W. Mol reports that he is supported by a NHMRC Investigator grant (GNT1176437), and has been a consultant for ObsEva, Merck, Merck KGaA, iGenomix and Guerbet. He has received research support from Merck and Guerbet. The other authors did not report any potential conflicts of interest.
Presented at the Society for Maternal-Fetal Medicine's 41st Annual Pregnancy Meeting, held virtually, January 25–30, 2021.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C186.
